4.0 Article

Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Ophthalmology

Bevacizumab and ranibizumab tachyphylaxis in the treatment of choroidal neovascularisation

Julie L. Gasperini et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2012)

Article Ophthalmology

Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab

Maria Salling Eghoj et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2012)

Article Ophthalmology

TACHYPHYLAXIS AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION

Farzin Forooghian et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)

Article Ophthalmology

SAFETY OF REPEAT INTRAVITREAL INJECTIONS OF BEVACIZUMAB VERSUS RANIBIZUMAB Our Experience After 2,000 Injections

Ioannis D. Ladas et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)

Article Medicine, General & Internal

Ranibizumab for neovascular age-related macular degeneration

Philip J. Rosenfeld et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Medicine, General & Internal

Ranibizumab versus verteporfin for neovascular age-related macular degeneration

David M. Brown et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)